Celgene

This study is testing an experimental treatment called JCAR017, a type of CAR-T cell therapy, in adults whose slow-growing non-Hodgkin lymphoma has come back or hasn't responded to prior treatments. Doctors will collect a patient's own immune cells, genetically modify them to bet…

This study is testing a new oral drug called CC-99282 for people with non-Hodgkin lymphoma that has come back or hasn't responded to previous treatments. Researchers want to find the safest and most effective dose, both when given alone and when combined with other lymphoma drugs…

This study is testing a new drug called CC-220 for people with multiple myeloma, a type of blood cancer. Researchers want to find the safest and most effective dose, both when given alone and when combined with other standard cancer treatments. The trial includes people whose can…

This large, late-stage study is testing whether adding an experimental drug called golcadomide to standard chemotherapy (R-CHOP) works better and is safe for people newly diagnosed with high-risk large B-cell lymphoma. It will involve about 850 participants who will be randomly a…

This study aims to check the long-term safety of an investigational drug called CC-93538 for people with eosinophilic esophagitis (EoE), a chronic inflammatory condition of the esophagus. It is open to about 368 adults and adolescents who have already taken the drug in earlier, r…

This study is testing whether adding a personalized immune cell therapy (called ide-cel) to standard maintenance medication (lenalidomide) works better than the standard medication alone for adults with newly diagnosed multiple myeloma. It focuses on patients who had a stem cell …

This study is testing two new drug combinations for adults newly diagnosed with a specific genetic type of acute myeloid leukemia (AML) who are not healthy enough for standard intensive chemotherapy. The goal is to find safe and effective doses and see if adding a new targeted pi…

This study is testing whether adding a new drug called golcadomide to the standard treatment rituximab works better for people newly diagnosed with advanced follicular lymphoma. It aims to see if this combination can help more patients achieve a complete response and control the …

This study is monitoring the safety of the drug lenalidomide in older adults with newly diagnosed multiple myeloma who are not eligible for a stem cell transplant. It will compare the rate of heart problems and other side effects in patients taking lenalidomide versus those takin…